Related Experiment Video
Updated: Feb 2, 2026

Author Spotlight: Fu's Subcutaneous Needling for Knee Osteoarthritis Pain
Published on: March 24, 2023
EZH2 contributes to 5-FU resistance in gastric cancer by epigenetically suppressing FBXO32 expression
Chenyu Wang1, Xingwang Li1, Junjie Zhang1
1Department of Anorectal, Huaihe Hospital of Henan University, Kaifeng, 475000, People's Republic of China, hujhhnuniver@126.com.
Background:
Increasing evidence suggests the involvement of enhancer of zeste homologue 2 (EZH2) in chemoresistance of cancer treatment. Nevertheless, its function and molecular mechanisms in gastric cancer (GC) chemoresistance are still not well elucidated.
Materials And Methods:
In the present study, we investigated the functional role of EZH2 in 5-fluorouracil (5-FU) resistance of GC cells and discovered the underlying molecular mechanism.
Results:
Results revealed that EZH2 was upregulated in 5-FU-resistant GC tissues and cell lines. High ZEH2 expression was correlated with poor prognosis of GC patients. EZH2 knockdown enhanced 5-FU sensitivity of AGS/5-FU and SGC-7901/5-FU cells. Moreover, EZH2 could epigenetically suppress FBXO32 expression. FBXO32 overexpression could mimic the functional role of downregulated EZH2 in 5-FU resistance. FBXO32 knockdown counteracted the inductive effect of EZH2 inhibition on 5-FU sensitivity of AGS/5-FU and SGC-7901/5-FU cells. Furthermore, EZH2 knockdown facilitated 5-FU sensitivity of 5-FU-resistant GC cells in vivo.
Conclusion:
In summary, EZH2 depletion overcame 5-FU resistance in GC by epigenetically silencing FBXO32, providing a novel therapeutic target for GC chemoresistance.
Insights
Enhancer of zeste homologue 2 (EZH2) promotes gastric cancer chemoresistance by silencing FBXO32. EZH2 depletion overcomes 5-fluorouracil resistance, offering a new therapeutic target for gastric cancer.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Enhancer of zeste homologue 2 (EZH2) is implicated in cancer chemoresistance.
- Its specific role and mechanisms in gastric cancer (GC) chemoresistance remain unclear.
Purpose of the Study:
- To investigate the role of EZH2 in 5-fluorouracil (5-FU) resistance in GC.
- To elucidate the molecular mechanisms underlying EZH2-mediated chemoresistance.
Main Methods:
- Analysis of EZH2 expression in 5-FU-resistant GC tissues and cell lines.
- Assessment of EZH2 knockdown and FBXO32 overexpression effects on 5-FU sensitivity in GC cells.
- In vivo studies to evaluate EZH2 inhibition in 5-FU-resistant GC models.
Main Results:
- EZH2 was upregulated in 5-FU-resistant GC, correlating with poor prognosis.
- EZH2 knockdown increased 5-FU sensitivity by epigenetically suppressing FBXO32.
- FBXO32 overexpression mimicked EZH2 inhibition, while FBXO32 knockdown reversed it.
- EZH2 inhibition enhanced 5-FU sensitivity in vivo.
Conclusions:
- EZH2 depletion overcomes 5-FU resistance in GC by epigenetically silencing FBXO32.
- EZH2 represents a potential therapeutic target for overcoming chemoresistance in gastric cancer.
Related Concept Videos
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
Treatment Resistant Cancers
What is Gene Expression?
Gene expression is the process in which DNA directs the synthesis of functional products, that is, proteins. Cells can regulate gene expression at various stages. It allows organisms to generate different cell types and enables cells to adapt to internal and external factors.
Genetic Information Flows from DNA to RNA to Protein
A gene is a stretch of DNA that serves as the blueprint for functional RNAs and proteins. Since DNA is made up of nucleotides and proteins consist of amino...
Binet's Contribution to Measures of Intelligence
Gastric Motility
Peristaltic Waves and Chyme Formation
Upon food entry, the stomach initiates...

